Literature DB >> 6095963

Differential effects of D600, nifedipine and dantrolene sodium on excitation-secretion coupling and presynaptic beta-adrenoceptor responses in rat atria.

K M Callanan, A K Keenan.   

Abstract

The stimulation-evoked release of tritium was measured from rat atria labelled with [3H]-noradrenaline. The calcium dependence of evoked release and the facilitation of this release via activation of presynaptic beta-adrenoceptors were examined using D600 (methoxyverapamil), nifedipine and dantrolene sodium. Both D600 and nifedipine at dose levels of 20 and 100 microM inhibited evoked release. Dantrolene (20, 100 microM) reduced release by 25%, the effect being maximal at 20 microM. In the presence of 20 nM isoprenaline, a facilitation of evoked release occurred, which was blocked by 0.1 microM (-)-propranolol. The facilitatory action of isoprenaline was abolished by omission of calcium from the buffer, or by D600 or nifedipine, (100 microM). In contrast, the response to isoprenaline was not modified by dantrolene (20, 100 microM). It is concluded that the evoked release of noradrenaline (NA) utilizes Ca from both intra- and extracellular sources and that isoprenaline increases NA secretion by promoting the depolarization-induced influx of Ca.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095963      PMCID: PMC1987072          DOI: 10.1111/j.1476-5381.1984.tb16240.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Dual adreoceptor-mediated control of noradrenaline secretion from human vasoconstrictor nerves: facilitation by BETA-receptors and inhibitor by alpha-receptors.

Authors:  L Stj-5aarne; J Brundin
Journal:  Acta Physiol Scand       Date:  1975-05

2.  [Noradrenalin loss from the isolated rabbit heart following sympathetic nerve irritation and its pharmacological alteration].

Authors:  S HUKOVIC; E MUSCHOLL
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1962

3.  Possible role of a beta-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism.

Authors:  E Adler-Graschinsky; S Z Langer
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

4.  Dantrolene and A13187 ionophore: specific action on calcium channels revealed by the aequorin method.

Authors:  J E Desmedt; K Hainaut
Journal:  Biochem Pharmacol       Date:  1979-04-01       Impact factor: 5.858

Review 5.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.

Authors:  A Fleckenstein
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

Review 6.  Common mechanisms of hormone secretion.

Authors:  J M Trifaró
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

7.  Inhibitory effects of verapamil, prenylamine and D 600 on Ca2+-dependent noradrenaline release from the sympathetic nerves of isolated rabbit hearts.

Authors:  M Göthert; P Nawroth; H Neumeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

8.  Activation of prejunctional beta-adrenoceptors in rat atria by adrenaline applied exogenously or released as a co-transmitter.

Authors:  H Majewski; M J Rand; L H Tung
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

9.  Verapamil competitively inhibits alpha 1-adrenergic and muscarinic but not beta-adrenergic receptors in rat myocardium.

Authors:  J S Karliner; H J Motulsky; J Dunlap; J H Brown; P A Insel
Journal:  J Cardiovasc Pharmacol       Date:  1982 May-Jun       Impact factor: 3.105

Review 10.  Modulation of noradrenaline release through activation of presynaptic beta-adrenoreceptors.

Authors:  H Majewski
Journal:  J Auton Pharmacol       Date:  1983-03
View more
  1 in total

1.  The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum.

Authors:  D Dobrev; A S Milde; K Andreas; U Ravens
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.